GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000227411 | Cervix | HSIL_HPV | myeloid leukocyte activation | 23/737 | 223/18723 | 2.53e-05 | 7.53e-04 | 23 |
GO:004854515 | Cervix | HSIL_HPV | response to steroid hormone | 30/737 | 339/18723 | 3.22e-05 | 9.13e-04 | 30 |
GO:003196014 | Cervix | HSIL_HPV | response to corticosteroid | 19/737 | 167/18723 | 3.29e-05 | 9.16e-04 | 19 |
GO:00100424 | Cervix | HSIL_HPV | response to manganese ion | 6/737 | 20/18723 | 8.80e-05 | 1.92e-03 | 6 |
GO:000717913 | Cervix | HSIL_HPV | transforming growth factor beta receptor signaling pathway | 20/737 | 198/18723 | 1.12e-04 | 2.33e-03 | 20 |
GO:003158914 | Cervix | HSIL_HPV | cell-substrate adhesion | 30/737 | 363/18723 | 1.12e-04 | 2.34e-03 | 30 |
GO:004573215 | Cervix | HSIL_HPV | positive regulation of protein catabolic process | 22/737 | 231/18723 | 1.24e-04 | 2.49e-03 | 22 |
GO:001063213 | Cervix | HSIL_HPV | regulation of epithelial cell migration | 25/737 | 292/18723 | 2.39e-04 | 4.18e-03 | 25 |
GO:003367413 | Cervix | HSIL_HPV | positive regulation of kinase activity | 34/737 | 467/18723 | 4.49e-04 | 6.63e-03 | 34 |
GO:001063414 | Cervix | HSIL_HPV | positive regulation of epithelial cell migration | 17/737 | 176/18723 | 5.99e-04 | 8.37e-03 | 17 |
GO:005138414 | Cervix | HSIL_HPV | response to glucocorticoid | 15/737 | 148/18723 | 7.50e-04 | 9.99e-03 | 15 |
GO:007156013 | Cervix | HSIL_HPV | cellular response to transforming growth factor beta stimulus | 21/737 | 250/18723 | 9.34e-04 | 1.18e-02 | 21 |
GO:007155913 | Cervix | HSIL_HPV | response to transforming growth factor beta | 21/737 | 256/18723 | 1.26e-03 | 1.48e-02 | 21 |
GO:000717813 | Cervix | HSIL_HPV | transmembrane receptor protein serine/threonine kinase signaling pathway | 26/737 | 355/18723 | 1.86e-03 | 1.97e-02 | 26 |
GO:005122214 | Cervix | HSIL_HPV | positive regulation of protein transport | 23/737 | 303/18723 | 2.11e-03 | 2.17e-02 | 23 |
GO:005159214 | Cervix | HSIL_HPV | response to calcium ion | 14/737 | 149/18723 | 2.29e-03 | 2.28e-02 | 14 |
GO:004586013 | Cervix | HSIL_HPV | positive regulation of protein kinase activity | 27/737 | 386/18723 | 2.93e-03 | 2.74e-02 | 27 |
GO:190495114 | Cervix | HSIL_HPV | positive regulation of establishment of protein localization | 23/737 | 319/18723 | 4.01e-03 | 3.45e-02 | 23 |
GO:007121612 | Cervix | HSIL_HPV | cellular response to biotic stimulus | 19/737 | 246/18723 | 4.09e-03 | 3.50e-02 | 19 |
GO:003461214 | Cervix | HSIL_HPV | response to tumor necrosis factor | 19/737 | 253/18723 | 5.52e-03 | 4.45e-02 | 19 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ADA | SNV | Missense_Mutation | | c.217N>A | p.Ala73Thr | p.A73T | P00813 | protein_coding | deleterious(0.01) | benign(0.386) | TCGA-A2-A0CM-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | PD |
ADA | SNV | Missense_Mutation | rs748974674 | c.935N>G | p.Lys312Arg | p.K312R | P00813 | protein_coding | tolerated(0.15) | benign(0.007) | TCGA-A8-A08O-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | PD |
ADA | SNV | Missense_Mutation | rs121908721 | c.872N>T | p.Ser291Leu | p.S291L | P00813 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-C8-A1HE-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ADA | insertion | Frame_Shift_Ins | novel | c.1006_1007insTGGGTACTACAAGTTG | p.Pro336LeufsTer9 | p.P336Lfs*9 | P00813 | protein_coding | | | TCGA-A7-A0D9-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | SD |
ADA | insertion | Frame_Shift_Ins | novel | c.946_947insT | p.Gly316ValfsTer4 | p.G316Vfs*4 | P00813 | protein_coding | | | TCGA-A8-A06P-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unspecific | | SD |
ADA | insertion | Nonsense_Mutation | novel | c.944_945insCCCAGGCTGAATAAGTCCATTCCTGCACGTGTCTGCGA | p.Met315IlefsTer4 | p.M315Ifs*4 | P00813 | protein_coding | | | TCGA-A8-A06P-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unspecific | | SD |
ADA | SNV | Missense_Mutation | | c.347C>T | p.Pro116Leu | p.P116L | P00813 | protein_coding | deleterious(0.01) | possibly_damaging(0.614) | TCGA-EX-A69L-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
ADA | SNV | Missense_Mutation | novel | c.340N>A | p.Pro114Thr | p.P114T | P00813 | protein_coding | deleterious(0) | probably_damaging(0.984) | TCGA-ZJ-AAX4-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Unknown | Unknown | SD |
ADA | SNV | Missense_Mutation | | c.824N>G | p.Asp275Gly | p.D275G | P00813 | protein_coding | tolerated(0.15) | benign(0.045) | TCGA-AA-3663-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
ADA | SNV | Missense_Mutation | | c.754N>A | p.Leu252Met | p.L252M | P00813 | protein_coding | deleterious(0.05) | probably_damaging(0.987) | TCGA-AA-3864-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | 2,3-DIDEOXYADENOSINE | | 3496090 |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | PENTOSTATIN | PENTOSTATIN | |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | DIPYRIDAMOLE | DIPYRIDAMOLE | |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | inhibitor | 178101507 | PENTOSTATIN | |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | 6-METHYLMERCAPTOPURINE RIBOSIDE | | 10102 |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | Ex vivo adenosine deaminase-transduced hematopoietic stem cell therapy | | |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | HYDROCORTISONE | HYDROCORTISONE | 2395837 |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | Pentostatin | PENTOSTATIN | |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | CORDYCEPIN | CORDYCEPIN | 24283924 |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | COBALT | | 9144774 |